Literature DB >> 7283023

Diagnosis of acute cholecystitis using hepatobiliary scan with technetium-99m PIPIDA.

M T Bennett, M I Sheldon, L V dos Remedios, P M Weber.   

Abstract

Sixty patients were evaluated for acute abdominal pain using technetium-99m PIPIDA hepatobiliary imaging. The sensitivity of the test was 90.6 percent in all patients and the accuracy was 93.3 percent. In the evaluation of acutely ill patients with right upper quadrant pain, fever, nausea and vomiting, hepatobiliary imaging with PIPIDA is the preferred test for diagnosing acute cholecystitis. If the test is positive, disease of the gallbladder and probably acute cholecystitis are present. Early operation can proceed if desirable. If the test is negative and the bilirubin level is less than 5.0 mg/dl, acute cholecystitis is not present. In such cases conservative treatment is appropriate, and follow-up tests should be performed to evaluate the possibility of chronic cholecystitis. When the bilirubin level exceeds 5.0 mg/dl, the test is often indeterminate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283023     DOI: 10.1016/0002-9610(81)90343-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  The cost-effectiveness of early or delayed surgery in acute cholecystitis.

Authors:  G Alinder; P Herlin; B Lindgren; T Holmin
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

2.  Diagnostic evaluation of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan in acute cholecystitis.

Authors:  T Takada; H Yasuda; K Uchiyama; H Hasegawa; J Shikata; Y Kuniyasu; K Takada
Journal:  Gastroenterol Jpn       Date:  1988-10

3.  Association between false negative hepatobiliary scans and initial gallbladder visualization after 30 min.

Authors:  R J Hicks; M J Kelly; V Kalff
Journal:  Eur J Nucl Med       Date:  1990

4.  Cholecystitis and cholelithiasis in children and adolescents.

Authors:  E R Cheng; M I Okoye
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.